Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients

OBJECTIVES: To assess whether contralateral parenchymal enhancement reproduces as an independent biomarker for patient survival in an independent patient cohort from a different cancer institution. METHODS: This is a HIPAA-compliant IRB approved retrospective study. Patients with ER-positive/HER2-ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Radiol
Autors principals: van der Velden, Bas H. M., Sutton, Elizabeth J., Carbonaro, Luca A., Pijnappel, Ruud M., Morris, Elizabeth A., Gilhuijs, Kenneth G. A.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Breast
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182741/
https://ncbi.nlm.nih.gov/pubmed/29736850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-018-5470-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars